We decided to induce synthetic lethality in mice after tumors reached a certain size rather than at the time of xenotransplantation, since this approach better mimics a potential therapeutic intervention in patients with VPS4B‐deficient CRC tumors. Here, VPS4B is linked to colorectal carcinoma.